Annual or biennial lung cancer CT screening?

Journal of Thoracic Disease

Volumn 8, Issue 9, 2016, Pages 2424-2426

  Karachaliou, Niki ^a   Sosa, Aaron E ^a   Rosell, Rafael ^b,c  

^a HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^b Germans Trias i Pujol Research Institute in Health Sciences   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICIPATORY ANXIETY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCULATING TUMOR CELL; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NODULE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORAX RADIOGRAPHY;

EID: 84991212924     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2016.09.20     Document Type: Editorial

References (11)

1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Field JK, van Klaveren R, Pedersen JH, et al. European randomized lung cancer screening trials: Post NLST. J Surg Oncol 2013;108:280-6.
3. Couraud S, Cortot AB, Greillier L, et al. From randomized trials to the clinic: is it time to implement individual lungcancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF). Ann Oncol 2013;24:586-97.
4. Roberts H, Walker-Dilks C, Sivjee K, et al. Screening high-risk populations for lung cancer: guideline recommendations. J Thorac Oncol 2013;8:1232-7.
5. Field JK, Oudkerk M, Pedersen JH, et al. Prospects for population screening and diagnosis of lung cancer. Lancet 2013;382:732-41.
6. Patz EF Jr, Greco E, Gatsonis C, et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016;17:590-9.
7. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-15.
8. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.
9. Duffy SW, Field JK, Allgood PC, et al. Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer 2014;110:1834-40.
10. Hensing TA, Salgia R. Molecular biomarkers for future screening of lung cancer. J Surg Oncol 2013;108:327-33.
11. Ilie M, Hofman V, Long-Mira E, et al. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One 2014;9:e111597.